Publication Name	World Journal of Gastroenterology
Manuscript ID	35399
Country	South Korea

Received	2017-07-13 05:07
Peer-Review Started	2017-07-13 07:37
To Make the First Decision	2017-08-10 00:15
Return for Revision	2017-08-10 07:55
Revised	2017-08-25 03:44
Second Decision	2017-09-05 09:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-09-05 18:28
Articles in Press	2017-09-05 18:28
Publication Fee Transferred	2017-09-27 04:13
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-10-24 04:09
Publish the Manuscript Online	2017-11-05 00:48

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Jang Ho Cho, Jae Yun Lim and Jae Yong Cho
ORCID	Author(s) ORCID Number Jang Ho Cho http://orcid.org/0000-0002-3429-4321 Jae Yun Lim http://orcid.org/0000-0002-7321-9068 Jae Yong Cho http://orcid.org/0000-0002-0926-1819
Funding Agency and Grant Number
Corresponding Author	Jae Yong Cho, MD, PhD, Full Professor, Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Dogok 1-dong, Gangnam-gu, Seoul 135-720, South Korea. chojy@yuhs.ac
Key Words	Human epidermal growth factor 2; Trastuzumab; Gastric neoplasm
Core Tip	Our study aimed to investigate human epidermal growth factor 2 (HER2) overexpression and validate its prognostic effect in stage II-III gastric cancer. Clinical data from 384 patients were analyzed. HER2-positive patients had inferior OS and RFS. Stage II-III HER2-positive patients might be potential candidates for targeted therapies involving trastuzumab.
Publish Date	2017-11-05 00:48
Citation	Cho JH, Lim JY, Cho JY. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer. World J Gastroenterol 2017; 23(41): 7407-7414
URL	http://www.wjgnet.com/1007-9327/full/v23/i41/7407.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i41.7407

Full Article (PDF)	WJG-23-7407.pdf
Full Article (Word)	WJG-23-7407.doc
Manuscript File	35399-Review.docx
Answering Reviewers	35399-Answering reviewers.pdf
Audio Core Tip	35399-Audio core tip.m4a
Biostatistics Review Certificate	35399-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	35399-Conflict-of-interest statement.pdf
Copyright License Agreement	35399-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	35399-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	35399-Language certificate.pdf
Peer-review Report	35399-Peer-review(s).pdf
Scientific Misconduct Check	35399-Scientific misconduct check.pdf
Scientific Editor Work List	35399-Scientific editor work list.pdf